HPV-IMMUNTHERAPIE

Patent europeic · EP3743436 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3743436
Numer da la dumonda
EP19743421
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
23-01-2019
Publitgà
02-12-2020
Concedì
26-08-2026
La protecziun finescha il pli tard
22-01-2039
Proxima taxa annuala scadenta
31-01-2027
Classas IPC
A61K 39/12 (2006.01)
A61K 35/17 (2025.01)
A61K 38/00 (2006.01)
A61K 35/15 (2025.01)
C07K 16/084 (2026.01)
A61K 38/17 (2006.01)
A61P 31/20 (2006.01)
A61K 39/00 (2006.01)
C12N 5/0783 (2010.01)
C12N 5/078 (2010.01)
C07K 14/005 (2006.01)
A61P 35/00 (2006.01)
Prioritad
US 201862621279 P 24.01.2018
Dumonda PCT
PCT/IB2019/000131 23.01.2019
Publicaziun PCT
WO2019/145792 01.08.2019
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 26-08-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 26.08.2026

Partidas

Inventur

KHANNA, Rajiv

Herston, QLD 4006, AU

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.